Biohybrid
materials, which are defined as engineered
functional
materials combining living components with nonliving synthetic materials,
are considered promising bioactive materials for applications in in
vivo tissue engineering. However, the rational design of biohybrid
materials applicable to in vivo tissue engineering faces major challenges
associated with techniques for combining living cells with nonliving
synthetic materials and cell sources. Here, we report injectable covalent
stem cell-combing biohybrid materials prepared via a bio-orthogonal
click cross-linking reaction of azide-modified adipose-derived stem
cells (N3[+]ADSCs), one of the most promising cell sources
utilized clinically, with alkyne-modified biocompatible alginate polymers.
The mechanical properties of the covalent stem cell-combining biohybrid
materials can be adapted to the mechanical properties of the surrounding
environment in which they are transplanted by alternating the number
of N3[+]ADSCs, the concentration of alkyne-modified alginate,
and the number of alkyne groups. Importantly, ADSCs in the covalent
biohybrid materials expressed a high level of CD-105, a marker for
undifferentiated mesenchymal stem cells, in the body in the absence
of differentiation signals, whereas very little CD-105 was expressed
in the control physical cell-loading materials, demonstrating that
this covalent stem cell-combining approach results in enhanced retention
of the material’s “stemness” and controlled differentiation
in the body. We assessed the potential utility of the covalent stem
cell-combining biohybrid materials for in vivo tissue engineering
using a murine severe skeletal muscle defect-healing model. Importantly,
all of the tissues regenerated by the covalent biohybrid material
treatment expressed MYH3, a myogenic marker protein, whereas no expression
of MYH3 was detected in the tissues reconstructed by treatment with
control physical stem cell-loading materials and Matrigel, indicating
that this covalent stem cell-combining approach results in controlled
differentiation in the body. Our data demonstrate the potential utility
of covalent stem cell-combining biohybrid materials with host tissue-integrative
and controlled differentiation capabilities available for in vivo
tissue engineering.